This is the FDA's latest emergency use authorization.

They're authorizing boosters for kids.

The first booster, FDA authorizes Pfizer COVID booster dose for kids ages five to 11 years old.

None of this could happen if it wasn't for Javier Bacera.

He's the Secretary of HHS and he extended, we reported this about a month ago.

He extended the COVID public health emergency for another 90 days that was in the headlines.

And what that did was that allowed these emergency use authorizations for vaccines to stay valid

and also for them to do what they just did with the FDA is to push more through for these kids.

So even though there is no emergency for kids, we've covered the numbers.

There's no hospitalization emergencies. There's no mortality emergencies associated with COVID-19.

These kids have almost 0% risk on those two factors and a low case correlation to that.

But let's go right, okay, so let's go right to the FDA press release because we didn't get a

verpac meeting on this one. We received a press release. Coronavirus update, FDA expands eligibility

of Pfizer, COVID-19 vaccine booster doses for children five through 11 years old.

Let's dig into this great press release. It says here, the safety.

Now, how did they determine the safety? The safety of a single booster dose, the Pfizer-BioNTech COVID-19

vaccine in the stage group was assessed in approximately 400 children who received a booster dose.

So there you go. You're going to send it to about a million plus children throughout the United

States. Now it says here, the FDA did not hold a meeting of its vaccine-related biological products

advisory committee on today's action as the agency previously convened the committee for extensive

discussions regarding the use of booster doses of COVID-19 vaccines. And after review of Pfizer's

EUA request, the FDA concluded that the request did not raise questions that would benefit from

...